This practice point offers evidence-based guidance for provincial/territorial immunization programs, clinics and office practices on how to address hesitancy and improve vaccine uptake rates. Steps to take include the following: 1) Detecting under-immunized subgroups (which requires record-keeping), diagnosis and targeted interventions; 2) Educating all health care workers involved with immunization on best practices; 3) Employing evidence-based strategies to increase uptake, including reminders, convenient clinic hours and locations, and tailored communication; 4) Educating children, youth and adults on the importance of immunization for health; and 5) Working collaboratively across provincial/territorial jurisdictions and with the federal government, nongovernmental organizations, community leaders and health services.
Chart that shows adults how frequently they need to get certain vaccines.
Announcing the publication of the WHO immunological basis for immunization series module on influenza vaccines
In 2017, the World Health Organization (WHO) published a document aimed at facilitating influenza vaccine introduction and use in low- and middle-income countries. The document, “The Immunological Basis for Immunization Series: Influenza Vaccines”, is freely available on the WHO website. The main purpose of this document is to give immunization managers and vaccination professionals an authoritative but easily-understood overview of the scientific basis of influenza vaccination and the immunological basis for the WHO position on influenza vaccines. The influenza vaccine document comprises one module of the WHO Immunological Basis for Immunization series. The immunization community is invited to use these references; it is hoped that the influenza vaccine module will be a valuable resource for persons who manage and monitor influenza vaccine programs, particularly in low- and middle-income countries.
Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019
The National Advisory Committee on Immunization (NACI): Canadian Immunization Guide Chapter on Influenza and Statement on Seasonal Influenza Vaccine for 2018–2019 updates NACI’s recommendations regarding the use of seasonal influenza vaccines.
This strategy is grounded in several communications guiding principles: putting the health of Canadians first; providing timely and sound information; communicating in a coordinated fashion from across all levels of government; protecting confidentiality; and monitoring and adapting to the public’s perception of risk. The Annex outlines a risk communications approach, proposes triggers for action based on pandemics of varying impact, and includes a Communication Protocol that will be used countrywide in the event of a pandemic.
Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018–2019
Le présent document, intitulé Comité consultatif national de l’immunisation (CCNI) : Chapitre sur la grippe du Guide canadien d’immunisation et Déclaration sur la vaccination antigrippale pour la saison 2018-2019, met à jour les recommandations du CCNI concernant l’utilisation de vaccins antigrippaux saisonniers.
Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials
An adjuvanted herpes zoster (HZ) subunit vaccine, HZ/su, demonstrated high efficacy against HZ and postherpetic neuralgia (PHN) in two randomized, observer-blind, placebo-controlled trials in adults aged >50 and >70 years (ZOE-50 and ZOE-70, respectively). Data from ZOE-50 and ZOE-70 trials were analyzed to evaluate the efficacy of HZ/su against
mortality, hospitalizations, and non-PHN complications of HZ including HZ-associated vasculitis, stroke, and disseminated, ophthalmic, neurologic, and visceral diseases.